Product References
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.
Nature communications
Luo Z,Xin D,Liao Y,Berry K,Ogurek S,Zhang F,Zhang L,Zhao C,Rao R,Dong X,Li H,Yu J,Lin Y,Huang G,Xu L,Xin M,Nishinakamura R,Yu J,Kool M,Pfister SM,Roussel MF,Zhou W,Weiss WA,Andreassen P,Lu QR
Fri Feb 10 00:00:00 EST 2023
C11orf54 promotes DNA repair via blocking CMA-mediated degradation of HIF1A.
Communications biology
Tan J,Wang W,Liu X,Xu J,Che Y,Liu Y,Hu J,Hu L,Li J,Zhou Q
Mon Jun 05 00:00:00 EDT 2023
Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity.
Cell biology and toxicology
Luo Q,Pan Y,Fu Q,Zhang X,Zhou S,Yu P,Tian H,Liu P,Chen S,Zhang H,Qin T
Sun Oct 01 00:00:00 EDT 2023
Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity.
Cell biology and toxicology
Luo Q,Pan Y,Fu Q,Zhang X,Zhou S,Yu P,Tian H,Liu P,Chen S,Zhang H,Qin T
Sun Oct 01 00:00:00 EDT 2023
Inhibition of Checkpoint Kinase 1 (CHK1) Upregulates Interferon Regulatory Factor 1 (IRF1) to Promote Apoptosis and Activate Anti-Tumor Immunity via MICA in Hepatocellular Carcinoma (HCC).
Cancers
Li X,Huang J,Wu Q,Du Q,Wang Y,Huang Y,Cai X,Geller DA,Yan Y
Mon Jan 30 00:00:00 EST 2023
Inhibition of Checkpoint Kinase 1 (CHK1) Upregulates Interferon Regulatory Factor 1 (IRF1) to Promote Apoptosis and Activate Anti-Tumor Immunity via MICA in Hepatocellular Carcinoma (HCC).
Cancers
Li X,Huang J,Wu Q,Du Q,Wang Y,Huang Y,Cai X,Geller DA,Yan Y
Mon Jan 30 00:00:00 EST 2023
Inhibition of Checkpoint Kinase 1 (CHK1) Upregulates Interferon Regulatory Factor 1 (IRF1) to Promote Apoptosis and Activate Anti-Tumor Immunity via MICA in Hepatocellular Carcinoma (HCC).
Cancers
Li X,Huang J,Wu Q,Du Q,Wang Y,Huang Y,Cai X,Geller DA,Yan Y
Mon Jan 30 00:00:00 EST 2023
Nanoengineered Gallium Ion Incorporated Formulation for Safe and Efficient Reversal of PARP Inhibition and Platinum Resistance in Ovarian Cancer.
Research (Washington, D.C.)
Li Y,Cen Y,Tu M,Xiang Z,Tang S,Lu W,Zhang H,Xu J
Mon Mar 20 00:00:00 EDT 2023
Combined Inactivation of CTPS1 and ATR Is Synthetically Lethal to MYC-Overexpressing Cancer Cells.
Cancer research
Sun Z,Zhang Z,Wang QQ,Liu JL
Tue Mar 15 00:00:00 EDT 2022
Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.
Cell death and differentiation
Zhao Y,Huang X,Zhu D,Wei M,Luo J,Yu S,Tian Y,Zheng X
Thu Dec 01 00:00:00 EST 2022
ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells.
Biochemical and biophysical research communications
Hu X,Pei D,Ci M,Zhang G,Li B,Wang J,Shen Y,Zhai X,Liang P,Cui H
Sat Apr 09 00:00:00 EDT 2022
G-quadruplex DNA structures in human stem cells and differentiation.
Nature communications
Zyner KG,Simeone A,Flynn SM,Doyle C,Marsico G,Adhikari S,Portella G,Tannahill D,Balasubramanian S
Mon Jan 10 00:00:00 EST 2022
Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells.
Cell death discovery
Guo H,Xiao Y,Yuan Z,Yang X,Chen J,Chen C,Wang M,Xie L,Chen Q,Tong Y,Zhang Q,Bai Y
Mon Mar 14 00:00:00 EDT 2022
Induction of Mitosis Delay and Apoptosis by CDDO-TFEA in Glioblastoma Multiforme.
Frontiers in pharmacology
Tsai TH,Lieu AS,Huang TY,Kwan AL,Lin CL,Hsu YC
Sat Dec 04 00:00:00 EST 2021
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia.
Haematologica
Li X,Su Y,Hege K,Madlambayan G,Edwards H,Knight T,Polin L,Kushner J,Dzinic SH,White K,Yang J,Miller R,Wang G,Zhao L,Wang Y,Lin H,Taub JW,Ge Y
Sat May 01 00:00:00 EDT 2021
MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway.
EBioMedicine
Ling Q,Li F,Zhang X,Mao S,Lin X,Pan J,Ye W,Wei W,Qian Y,Hu C,Huang X,Wang J,Wang H,Huang J,Wang Y,Jin J
Thu Jul 01 00:00:00 EDT 2021
Azidothymidine (AZT) Inhibits Proliferation of Human Ovarian Cancer Cells by Regulating Cell Cycle Progression.
Anticancer research
Hsieh Y,Tseng JJ
Thu Oct 01 00:00:00 EDT 2020
UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Journal of experimental & clinical cancer research : CR
Sun J,Zhu Z,Li W,Shen M,Cao C,Sun Q,Guo Z,Liu L,Wu D
Wed Oct 21 00:00:00 EDT 2020
UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Journal of experimental & clinical cancer research : CR
Sun J,Zhu Z,Li W,Shen M,Cao C,Sun Q,Guo Z,Liu L,Wu D
Wed Oct 21 00:00:00 EDT 2020
A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells.
Medical oncology (Northwood, London, England)
Jin J,Mao S,Li F,Li X,Huang X,Yu M,Guo W,Jin J
Thu Aug 01 00:00:00 EDT 2019
RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
Clinical cancer research : an official journal of the American Association for Cancer Research
Yang X,Pan Y,Qiu Z,Du Z,Zhang Y,Fa P,Gorityala S,Ma S,Li S,Chen C,Wang H,Xu Y,Yan C,Ruth K,Ma Z,Zhang J
Sun Apr 01 00:00:00 EDT 2018
RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
Clinical cancer research : an official journal of the American Association for Cancer Research
Yang X,Pan Y,Qiu Z,Du Z,Zhang Y,Fa P,Gorityala S,Ma S,Li S,Chen C,Wang H,Xu Y,Yan C,Ruth K,Ma Z,Zhang J
Sun Apr 01 00:00:00 EDT 2018